Baker Tilly Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Baker Tilly Wealth Management's PFE Position: Q2 2026 in Review
Baker Tilly Wealth Management reduced its Pfizer (PFE) stake by 9.7% in Q2 2026, selling an estimated $26.9K and leaving 9,590 shares worth $231K. The position accounts for 0.05% of the portfolio, ranked #259.
Baker Tilly Wealth Management first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $5.5M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Baker Tilly Wealth Management held 9,590 shares of Pfizer worth $231K as of Q2 2026.
- Baker Tilly Wealth Management sold 1,030 Pfizer shares in Q2 2026, an estimated $26.9K.
- Pfizer made up 0.05% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #259 holding.
- Baker Tilly Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
- Baker Tilly Wealth Management's Pfizer position peaked at $5.5M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.